Valuation: Neuland Laboratories Limited

Market Cap 293B 3.06B 2.67B 2.52B 2.29B 4.28B 4.3B 30.17B 11.64B 149B 11.49B 11.23B 480B P/E 2027 *
61.4x
P/E 2028 * 47x
Enterprise Value 296B 3.09B 2.69B 2.54B 2.31B 4.32B 4.34B 30.43B 11.74B 151B 11.59B 11.33B 484B EV / Sales 2027 *
12.1x
EV / Sales 2028 * 10.1x
Free-Float
62.26%
Yield 2027 *
0.1%
Yield 2028 * 0.13%
1 day+0.97%
1 week-2.81%
Current month-0.26%
1 month-1.81%
3 months+31.85%
6 months+89.15%
Current year+50.59%
1 week 21,858.35
Extreme 21858.35
23,426.8
1 month 21,858.35
Extreme 21858.35
24,235.05
Current year 11,500
Extreme 11500
24,235.05
1 year 11,500
Extreme 11500
24,235.05
3 years 3,528
Extreme 3528
24,235.05
5 years 965.85
Extreme 965.85
24,235.05
10 years 247.3
Extreme 247.3
24,235.05
Manager TitleAgeSince
Chief Executive Officer 47 31/03/2026
Director of Finance/CFO - 22/11/2022
Chief Tech/Sci/R&D Officer - 28/02/2023
Director TitleAgeSince
Director/Board Member 50 31/12/2001
Chairman 82 06/01/1984
Director/Board Member 47 28/02/2007
Change 5-day change 1-year change 3-year change Capi.($)
+0.97%-2.81%+48.28%+526.41% 3.06B
+0.04%+3.34%+53.32%+100.52% 1,028B
-0.09%+1.66%+53.24%+66.45% 651B
-0.02%+2.66%+18.65%+71.97% 466B
-1.22%+3.66%+34.59%+38.81% 346B
-0.79%+2.73%+17.73%+25.11% 266B
+0.58%+6.76%+10.58%+17.75% 259B
+1.55%+2.20%+35.12%+45.91% 208B
+0.79%+1.84%-27.55%-56.48% 191B
-0.52%+4.45%+31.57%+98.11% 186B
Average +0.13%+2.65%+27.55%+93.46% 360.48B
Weighted average by Cap. -0.04%+3.09%+34.86%+62.00%

Financials

2027 *2028 *
Net sales 24.43B 255M 222M 210M 190M 357M 358M 2.51B 969M 12.42B 957M 935M 39.97B 29.27B 305M 266M 251M 228M 427M 429M 3.01B 1.16B 14.88B 1.15B 1.12B 47.88B
Net income 4.8B 50.01M 43.61M 41.17M 37.39M 70.05M 70.34M 493M 190M 2.44B 188M 184M 7.85B 6.26B 65.29M 56.93M 53.76M 48.81M 91.46M 91.84M 644M 248M 3.19B 245M 240M 10.25B
Net Debt 2.56B 26.69M 23.28M 21.98M 19.96M 37.39M 37.55M 263M 102M 1.3B 100M 98.04M 4.19B 979M 10.21M 8.9M 8.4M 7.63M 14.3M 14.36M 101M 38.85M 498M 38.34M 37.49M 1.6B
Logo Neuland Laboratories Limited
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Employees
2,183
Date Price Change Volume
18/09/26 ₹22,875.70 +0.97% 4,026
17/09/26 ₹22,656.20 +0.01% 1,356
16/09/26 ₹22,653.10 +0.58% 2,147
15/09/26 ₹22,522.85 -4.31% 2,850
11/09/26 ₹23,536.20 -1.12% 2,445
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
22,875.70INR
Average target price
24,334.75INR
Spread / Average Target
+6.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NEULANDLAB Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!